Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome

$ 20.00

4.7
(417)
In stock
Description

Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome, Journal of Patient-Reported Outcomes

Carcinoid Tumour

JCM, Free Full-Text

Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis

Vitamins

JCM, Free Full-Text

Cancers, Free Full-Text

Effective strategies for adequate control of hormonal secretion in functioning neuroendocrine neoplasms - ScienceDirect

Management of Diarrhea in Patients With Carcinoid Syndrome. - Abstract - Europe PMC

Carcinoid Tumor: Practice Essentials, Background, Pathophysiology

Cancers, Free Full-Text

Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Clinical Diabetes and Endocrinology

PDF) Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-Controlled Study of Telotristat Ethyl

Frontiers Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders